Kynex Versus Refresh Plus Study in Subject With Dry Eye
NCT00809198 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 67
Last updated 2012-02-03
Summary
The effect of Kynex versus Refresh Plus in subjects with mild to moderate dry eye.
Conditions
- Dry Eye
Interventions
- OTHER
-
Sodium Hyaluronate
- OTHER
-
Carboxymethylcellulose sodium
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2009-05-31
- Completion
- 2009-05-31
More Related Trials
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00938704 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
NCT05661851 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
NCT02553772 ·Status: COMPLETED ·Phase: PHASE3
-
Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome
NCT01382225 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
NCT02819284 ·Status: COMPLETED ·Phase: PHASE3
-
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
NCT02813265 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
NCT06660290 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients
NCT01250171 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease
NCT05995392 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
A Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01211951 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
NCT00704275 ·Status: UNKNOWN ·Phase: PHASE4
-
A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01890941 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease
NCT00679718 ·Status: COMPLETED ·Phase: PHASE2
-
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
NCT00739349 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
NCT02188160 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01733992 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease
NCT03888183 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
NCT02455050 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00403715 ·Status: COMPLETED ·Phase: PHASE3
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
NCT05759208 ·Status: COMPLETED ·Phase: PHASE2